Piramal Pharma Limited — Important, 02-07-2025: General Updates

Piramal Pharma has announced a board meeting to consider the financial results for the quarter and half-year. The company reported a ₹5,285.71 Cr turnover and ₹8,170.88 Cr net worth. It serves over 100 countries, with exports contributing 68.55% of turnover. Businesses include pharmaceuticals manufacturing, contract development, critical care, and consumer healthcare. Piramal Pharma advanced sustainability with initiatives in energy efficiency, water conservation, waste management, and carbon reduction. Employee well-being and safety remain a priority, supported by rigorous training and health programs. Several penalties totaling over ₹225 Cr were noted, with ongoing appeals for some. No new orders or operational disruptions disclosed.